Ethoss
65% beta tri-calcium phosphate (ß-TCP) and 35% medical grade calcium sulfate (CaSO4) in 0.5cc syringes or 1.0cc syringes.
EthOss TCP is intended to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region.
Count and link only, sourced from the TGA's Database of Recalls, Product Alerts and Product Corrections. "Market actions" includes recalls, product alerts and product corrections — full detail stays on the TGA's own site.
No recorded changes yet — history accumulates with each release.
Data sourced from Australian Government publications · Not an official government service